Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is held by 271 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 24,519,192 | 10,220,672 | 71.48% | $304,773,556.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 17,907,815 | -47,158 | -0.26% | $225,638,469.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 14,298,520 | 224,867 | 1.60% | $180,161,353.00 |
| Rubric Capital Management LP | 31 Mar, 2026 | 12,334,941 | 0 | 0.00% | $155,420,257.00 |
| TPG GP A, LLC | 31 Mar, 2026 | 12,328,767 | 0 | 0.00% | $153,246,574.00 |
| TPG GP A, LLC | 31 Mar, 2026 | 12,328,767 | 0 | 0.00% | $155,342,464.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 11,324,933 | 11,324,933 | 0.00% | $140,768,917.00 |
| Rubric Capital Management LP | 31 Mar, 2026 | 11,037,589 | -1,297,352 | -10.52% | $137,197,231.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 7,585,034 | 7,585,034 | 0.00% | $94,281,973.00 |
| State Street Corp | 31 Mar, 2026 | 6,794,702 | 2,684,292 | 65.30% | $84,458,146.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 6,175,737 | 446,438 | 7.79% | $77,814,286.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 5,690,586 | 81,546 | 1.45% | $70,722,579.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 5,609,040 | 177,906 | 3.28% | $70,680,550.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 5,162,150 | 2,701,936 | 109.83% | $65,043,090.00 |
| Morgan Stanley | 31 Mar, 2026 | 4,818,099 | 1,315,018 | 37.54% | $60,708,057.00 |
| Morgan Stanley | 31 Mar, 2026 | 4,637,185 | -180,914 | -3.75% | $57,640,225.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 4,546,048 | 559,494 | 14.03% | $56,516,272.00 |
| State Street Corp | 31 Mar, 2026 | 4,110,410 | 136,662 | 3.44% | $51,791,166.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 3,986,554 | -48,079 | -1.19% | $50,239,137.00 |
| Assenagon Asset Management S.A. | 31 Mar, 2026 | 3,761,739 | 1,611,698 | 74.96% | $47,397,911.00 |